Listed

SeaStar Medical Holding Corp

ICUNasdaqCIK 1831868HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$615.0kRevenue, Q2 FY2026, three months to 2026-06-30$615.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 12, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$615.0kRevenue, Q2 FY2026, three months to 2026-06-30$615.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figure+82.0% on a year earlier
  • Gross margin91.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $561.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Revenue: $615.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figure−0.8 pts on a year earlier
  • Operating margin−616.4%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Revenue: $615.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figure−96.9 pts on a year earlier
  • Net margin−606.5%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Revenue: $615.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figure−14.2 pts on a year earlier
  • Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$615.0kGross margin 91.2%
Diluted EPS−$0.18, Q2 FY2025
SeaStar Medical Holding Corp, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$k68.0Revenue, Q3 FY2024, three months to 2024-09-30$68.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Report this figure67.0Revenue, Q4 FY2024, three months to 2024-12-31$67.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Report this figure293Revenue, Q1 FY2025, three months to 2025-03-31$293.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001437749-26-016764.Report this figure338Revenue, Q2 FY2025, three months to 2025-06-30$338.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figure183Revenue, Q3 FY2025, three months to 2025-09-30$183.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Report this figure420Revenue, Q4 FY2025, three months to 2025-12-31$420.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Report this figure495Revenue, Q1 FY2026, three months to 2026-03-31$495.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001437749-26-016764.Report this figure615Revenue, Q2 FY2026, three months to 2026-06-30$615.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figure
Gross margin%100.0%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $68.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Revenue: $68.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Report this figure100.0%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $67.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Revenue: $67.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Report this figure100.0%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $293.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001437749-26-016764.Revenue: $293.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001437749-26-016764.Report this figure92.0%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $311.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Revenue: $338.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figure92.3%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $169.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Revenue: $183.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Report this figure97.1%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $408.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Revenue: $420.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Report this figure90.7%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $449.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001437749-26-016764.Revenue: $495.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001437749-26-016764.Report this figure91.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $561.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Revenue: $615.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figure
Operating margin%(6552.9%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$4.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Revenue: $68.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Report this figure(7114.9%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$4.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Revenue: $67.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Report this figure(1304.4%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016764.Revenue: $293.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001437749-26-016764.Report this figure(519.5%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Revenue: $338.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figure(1955.7%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Revenue: $183.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Report this figure(718.1%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Revenue: $420.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Report this figure(727.9%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016764.Revenue: $495.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001437749-26-016764.Report this figure(616.4%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Revenue: $615.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figure
Net margin%(6585.3%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Revenue: $68.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Report this figure(6595.5%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$4.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Revenue: $67.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Report this figure(1287.4%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$3.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Revenue: $293.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001437749-26-016764.Report this figure(592.3%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Revenue: $338.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figure(1897.3%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Revenue: $183.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001437749-25-034884.Report this figure(691.4%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Revenue: $420.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797. Derived: 12-month figure less the 9-month figure.Report this figure(711.3%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Revenue: $495.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001437749-26-016764.Report this figure(606.5%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Revenue: $615.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027353.Report this figure
Diluted EPS$ per share(1.10)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0000950170-24-126498.Report this figurenot reported (Diluted EPS not reported)(0.44)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0000950170-25-071583.Report this figure(0.18)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001831868-25-000007.Report this figurenot reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)
Free cash flow$knot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$1.2mGross margin 95.7%
Diluted EPS−$6.63, FY2024
SeaStar Medical Holding Corp, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$knot reported (Revenue not reported)not reported (Revenue not reported)0.0Revenue, FY2023, twelve months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-27, accession 0000950170-25-046200.Report this figure135Revenue, FY2024, twelve months to 2024-12-31$135.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797.Report this figure1,234Revenue, FY2025, twelve months to 2025-12-31$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797.Report this figure
Gross margin%not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)not reported (Revenue of zero not reported)100.0%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $135.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001437749-26-009797.Revenue: $135.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797.Report this figure95.7%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $1.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001437749-26-009797.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797.Report this figure
Operating margin%not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue of zero not reported)(13216.3%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$17.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001437749-26-009797.Revenue: $135.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797.Report this figure(986.6%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$12.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001437749-26-009797.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797.Report this figure
Net margin%not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue of zero not reported)(18392.6%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$24.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001437749-26-009797.Revenue: $135.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797.Report this figure(984.6%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$12.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001437749-26-009797.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009797.Report this figure
Diluted EPS$ per share(0.63)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-30, accession 0000950170-23-011035.Report this figure(1.48)Diluted EPS, FY2022, twelve months to 2022-12-31−$1.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-04-16, accession 0000950170-24-044855.Report this figure(30.26)Diluted EPS, FY2023, twelve months to 2023-12-31−$30.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-27, accession 0000950170-25-046200.Report this figure(6.63)Diluted EPS, FY2024, twelve months to 2024-12-31−$6.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-27, accession 0000950170-25-046200.Report this figurenot reported (Diluted EPS not reported)
Free cash flow$knot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding SeaStar Medical Holding Corp
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BOOTHBAY FUND MANAGEMENT, LLC2026-06-30$899.9k245,200Unchanged
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$182.0k49,593Reduced−6,049
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$121.4k33,091Added+4,300
UBS Group AG2026-06-30$115.2k31,398Added+30,605
VANGUARD FIDUCIARY TRUST CO2026-06-30$50.3k13,692Unchanged
JANE STREET GROUP, LLC2026-06-30$46.4k12,634Reduced−15,326
NORTHERN TRUST CORP2026-06-30$38.2k10,402New+10,402
PNC Financial Services Group, Inc.2026-06-30$18.1k4,943Added+3,195
Tower Research Capital LLC (TRC)2026-06-30$5.0k1,356Reduced−39
GOLDMAN SACHS GROUP INC2026-06-30$3.7k211,381Unchanged

Recent filings

All 541 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

SeaStar Medical Holding Corp, recent filings
FiledFormWhat it isAccession number
2026-10-0520:20 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001437749-26-032035
2026-08-1220:46 ET10-QQuarterly reportPeriod 2026-06-300001437749-26-027353
2026-08-1220:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-26-027314
2026-07-0120:06 ET8-K5.02 Departure or appointment of officers or directors0001437749-26-022278
2026-06-2320:14 ET8-K/A5.02 Departure or appointment of officers or directors0001437749-26-021441
2026-06-1720:07 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001437749-26-020967
2026-05-1320:45 ET10-QQuarterly reportPeriod 2026-03-310001437749-26-016764
2026-05-1320:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-26-016726
2026-05-0712:38 ETS-1/ARegistration statement, amended0001213900-26-053076
2026-04-2920:10 ETDEF 14AProxy statementPeriod 2026-06-170001437749-26-013871

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 25, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1831868
Tickers
ICU, ICUCW
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
<br>Emerging growth company
Former names
LMF Acquisition Opportunities Inc (to 2022-10-27)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.